Health care startups that raised Series C
Source: FundingWatcher. Data as of 4 September 2026.
1,241
Companies
$45.2B
Last round total
100
Rows shown
4 September 2026
Data as of
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | AusperBio | Series C | $120.0M | 2026-08-27 | San Mateo | Biotech |
| 2 | Channel Medsystems | Series C | $30.0M | 2026-08-20 | Berkeley | Biotech |
| 3 | Realmind Biotech | Series C | 2026-08-20 | Nanjing | Biotech | |
| 4 | Bridge to Life | Series C | $110.0M | 2026-08-12 | Northbrook | Biotech |
| 5 | Epicrispr Biotechnologies | Series C | $90.0M | 2026-08-11 | South San Francisco | Biotech |
| 6 | Versa Vascular | Series C | $15.0M | 2026-08-11 | Santa Cruz | Health care |
| 7 | Hopstem | Series C | $29.6M | 2026-08-10 | Hangzhou | Biotech |
| 8 | Ratio Therapeutics | Series C | $70.0M | 2026-07-31 | Boston | Biotech |
| 9 | CoreMap | Series C | $37.0M | 2026-07-29 | Burlington | Biotech |
| 10 | Diyingjia Technology | Series C | $3.0M | 2026-07-28 | Beijing | Artificial intelligence |
| 11 | Delova Biotech | Series C | $88.6M | 2026-07-22 | Qixia | Biotech |
| 12 | Trellis Bioscience | Series C | $9.0M | 2026-07-16 | San Francisco | Biotech |
| 13 | InnoJin | Series C | $3.3M | 2026-07-16 | Tokyo | Education |
| 14 | Neko Health | Series C | $700.0M | 2026-07-15 | Stockholm | Artificial intelligence |
| 15 | Chai Discovery | Series C | $400.0M | 2026-07-14 | San Francisco | Artificial intelligence |
| 16 | NNB Nutrition | Series C | $29.5M | 2026-07-13 | Nanjing | Biotech |
| 17 | Pearl Health | Series C | $50.0M | 2026-07-08 | New York | Artificial intelligence |
| 18 | Allotera Therapeutics | Series C | $35.0M | 2026-07-08 | St Louis | Biotech |
| 19 | Cyllene Therapeutics | Series C | $37.7M | 2026-07-07 | Paris | Biotech |
| 20 | Huaxia Yingtai | Series C | $29.4M | 2026-07-06 | Changping | Biotech |
| 21 | iRegene | Series C | $38.3M | 2026-07-02 | Wuhan | Biotech |
| 22 | Flare Therapeutics | Series C | $85.0M | 2026-06-30 | Cambridge | Biotech |
| 23 | Assort Health | Series C | $120.0M | 2026-06-24 | San Francisco | Artificial intelligence |
| 24 | Cadence Solutions | Series C | $100.0M | 2026-06-23 | New York | Health care |
| 25 | Triveni Bio | Series C | $65.0M | 2026-06-17 | Watertown | Biotech |
| 26 | InStride Health | Series C | $30.0M | 2026-06-15 | Boston | Health care |
| 27 | Stepful | Series C | $55.0M | 2026-06-08 | New York | Education |
| 28 | Junhemeng Biopharmaceutical | Series C | $29.5M | 2026-06-08 | Hangzhou | Biotech |
| 29 | CereVasc | Series C | $85.0M | 2026-06-04 | Charlestown | Biotech |
| 30 | Semble | Series C | $40.3M | 2026-06-04 | London | Health care |
| 31 | Weikaier Pharmaceutical Technology | Series C | $29.6M | 2026-06-02 | Nanjing | Biotech |
| 32 | Tongee Medical Technology | Series C | $14.8M | 2026-06-01 | Hangzhou | Biotech |
| 33 | YolTech Therapeutics | Series C | $73.8M | 2026-05-29 | Minhang | Biotech |
| 34 | Prellis Biologics | Series C | 2026-05-27 | Berkeley | Biotech | |
| 35 | Fresha | Series C | $80.0M | 2026-05-21 | London | Commerce |
| 36 | Toregem BioPharma | Series C | $5.3M | 2026-05-19 | Kawaramachi | Biotech |
| 37 | Brightonix Imaging | Series C | $5.3M | 2026-05-19 | Seongdong | Health care |
| 38 | Accro Bioscience | Series C | $50.0M | 2026-05-18 | Suzhou | Biotech |
| 39 | Sound Wave Innovation | Series C | $16.7M | 2026-05-18 | Tokyo | Health care |
| 40 | Butterfly Medical | Series C | $21.0M | 2026-05-14 | Yoqne`am `illit | Health care |
| 41 | Henry | Series C | $19.0M | 2026-05-14 | Tokyo | Hardware |
| 42 | Cerevance | Series C | $20.0M | 2026-05-12 | Boston | Biotech |
| 43 | Genlight | Series C | 2026-05-12 | Hangzhou | Biotech | |
| 44 | ZSPepLib | Series C | $44.2M | 2026-05-11 | Zhuzhou | Health care |
| 45 | Curaway | Series C | 2026-05-10 | Hangzhou | Health care | |
| 46 | Caring | Series C | $27.3M | 2026-05-08 | Gangneung | Health care |
| 47 | Crown Affair | Series C | $5.0M | 2026-05-07 | New York | Health care |
| 48 | Iterative Health | Series C | $77.0M | 2026-04-30 | Cambridge | Artificial intelligence |
| 49 | Kashable | Series C | $60.0M | 2026-04-27 | New York | Fintech |
| 50 | AcuityMD | Series C | $80.0M | 2026-04-21 | Boston | Artificial intelligence |
| 51 | Tava Health | Series C | $40.0M | 2026-04-21 | Salt Lake City | Health care |
| 52 | Asto CT | Series C | $26.7M | 2026-04-21 | Madison | Health care |
| 53 | Storm Therapeutics | Series C | $56.0M | 2026-04-16 | Cambridge | Biotech |
| 54 | ADCendo | Series C | $75.0M | 2026-04-14 | Copenhagen | Biotech |
| 55 | Biobot Surgical Pte Ltd | Series C | $7.8M | 2026-04-09 | Singapore | Fintech |
| 56 | Endovascular Engineering | Series C | $80.0M | 2026-04-07 | Menlo Park | Health care |
| 57 | Conmind Medical | Series C | $29.1M | 2026-04-07 | Shenzhen | Biotech |
| 58 | Summus Global | Series C | $20.0M | 2026-04-07 | New York | Health care |
| 59 | Beijing Ansong Technology | Series C | $21.8M | 2026-04-03 | Fengtai | Education |
| 60 | XellSmart | Series C | $72.6M | 2026-04-01 | Minhang | Biotech |
| 61 | Terrestrial Bio | Series C | $50.0M | 2026-03-26 | Cambridge | Biotech |
| 62 | Endogenex | Series C | $50.0M | 2026-03-25 | Plymouth | Health care |
| 63 | Adonis | Series C | $40.0M | 2026-03-25 | New York | Artificial intelligence |
| 64 | Stedi | Series C | $50.0M | 2026-03-24 | New York | Health care |
| 65 | CellGenes Biotechnology | Series C | $14.5M | 2026-03-24 | Guangzhou | Biotech |
| 66 | Power Site | Series C | $14.5M | 2026-03-18 | Suzhou | Health care |
| 67 | Chaomu Technology | Series C | 2026-03-17 | Changping | Health care | |
| 68 | Wallaby Medical | Series C | 2026-03-17 | Laguna Hills | Health care | |
| 69 | Connext | Series C | $10.0M | 2026-03-16 | Daegu | Biotech |
| 70 | Mustbio | Series C | $23.3M | 2026-03-13 | Seoul | Biotech |
| 71 | XCath | Series C | $30.0M | 2026-03-12 | Houston | Hardware |
| 72 | Moxie | Series C | $25.0M | 2026-03-10 | New York | Health care |
| 73 | Cognito Therapeutics | Series C | $105.0M | 2026-03-05 | Cambridge | Biotech |
| 74 | ANEUVO | Series C | $22.0M | 2026-03-05 | Los Angeles | Biotech |
| 75 | Shenluo Medical | Series C | 2026-03-04 | Hangzhou | Health care | |
| 76 | Polares Medical | Series C | $50.0M | 2026-03-03 | Palo Alto | Health care |
| 77 | QL Biopharma | Series C | $72.8M | 2026-03-02 | Changping | Biotech |
| 78 | Lyka Pet Food | Series C | $67.0M | 2026-03-02 | Sydney | Health care |
| 79 | Singular Medical | Series C | $20.7M | 2026-03-02 | Suzhou | Health care |
| 80 | Technological Innovation | Series C | $23.0M | 2026-02-28 | Shanghai | Health care |
| 81 | Ruining Bio | Series C | $14.6M | 2026-02-28 | Jiading | Health care |
| 82 | Ultrahuman | Series C | $43.9M | 2026-02-27 | Bangalore | Biotech |
| 83 | Brainomix | Series C | $6.5M | 2026-02-24 | Oxford | Artificial intelligence |
| 84 | Elumn8 Medical | Series C | 2026-02-18 | Campbell | Health care | |
| 85 | Loyal | Series C | $100.0M | 2026-02-11 | San Francisco | Biotech |
| 86 | Neurent Medical | Series C | $74.5M | 2026-02-11 | Oranmore | Health care |
| 87 | Regend Therapeutics | Series C | $50.6M | 2026-02-11 | Suzhou | Biotech |
| 88 | Supertails | Series C | $30.0M | 2026-02-09 | Bangalore | Health care |
| 89 | Huaguan Biotechnology | Series C | $14.4M | 2026-02-04 | Beijing | Biotech |
| 90 | Colossal Biosciences | Series C | $60.0M | 2026-02-03 | Austin | Biotech |
| 91 | Contrea | Series C | 2026-01-23 | Tokyo | Health care | |
| 92 | Pee Safe | Series C | $32.0M | 2026-01-14 | Gurgaon | Health care |
| 93 | Nuclera | Series C | $12.0M | 2026-01-13 | Cambridge | Biotech |
| 94 | Zenitar | Series C | $86.0M | 2026-01-12 | Chengdu | Biotech |
| 95 | Inquis Medical | Series C | $75.0M | 2026-01-12 | Redwood City | Health care |
| 96 | bit.bio | Series C | $50.0M | 2026-01-09 | Cambridge | Biotech |
| 97 | Beacon Therapeutics | Series C | $75.0M | 2026-01-08 | Alachua | Biotech |
| 98 | Ukko | Series C | $45.0M | 2026-01-08 | Palo Alto | Biotech |
| 99 | Yike Polymers | Series C | 2026-01-08 | Shanghai | Hardware | |
| 100 | Soley Therapeutics | Series C | $200.0M | 2026-01-07 | San Francisco | Biotech |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,241.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Neko Health | Series C | $700.0M | 2026-07-15 | Stockholm | Artificial intelligence |
| 2 | Zwift | Series C | $450.0M | 2020-09-16 | Long Beach | Health care |
| 3 | Tubulis | Series C | $400.6M | 2025-10-15 | Munich | Biotech |
| 4 | Chai Discovery | Series C | $400.0M | 2026-07-14 | San Francisco | Artificial intelligence |
| 5 | Insitro | Series C | $400.0M | 2021-03-15 | South San Francisco | Artificial intelligence |
| 6 | Monogram Health | Series C | $375.0M | 2023-01-09 | Brentwood | Health care |
| 7 | ArsenalBio | Series C | $325.0M | 2024-09-04 | South San Francisco | Biotech |
| 8 | Truveta | Series C | $320.0M | 2025-01-13 | Bellevue | Health care |
| 9 | ACELYRIN | Series C | $300.0M | 2022-09-13 | Los Angeles | Biotech |
| 10 | Abogen Biosciences | Series C | $300.0M | 2021-11-29 | Suzhou | Biotech |
| 11 | Heyuan Biotechnology | Series C | $300.0M | 2020-06-01 | Shanghai | Biotech |
| 12 | Tencent Trusted Doctors | Series C | $250.0M | 2019-04-24 | Beijing | Health care |
| 13 | Ambience Healthcare | Series C | $243.0M | 2025-07-29 | San Francisco | Artificial intelligence |
| 14 | ProBio Inc. | Series C | $220.0M | 2023-01-18 | Pennington | Biotech |
| 15 | Tempo | Series C | $220.0M | 2021-04-13 | San Francisco | Biotech |
| 16 | Mojave Pharma | Series C | $220.0M | 2017-10-01 | Las Vegas | Biotech |
| 17 | Aviceda Therapeutics | Series C | $207.5M | 2025-01-07 | Cambridge | Biotech |
| 18 | InterVenn | Series C | $201.0M | 2021-08-02 | South San Francisco | Artificial intelligence |
| 19 | Soley Therapeutics | Series C | $200.0M | 2026-01-07 | San Francisco | Biotech |
| 20 | Flo Health | Series C | $200.0M | 2024-07-30 | London | Artificial intelligence |
| 21 | Edge Medical Robotics | Series C | $200.0M | 2021-11-05 | Shenzhen | Hardware |
| 22 | NiKang Therapeutics | Series C | $200.0M | 2021-05-26 | Wilmington | Biotech |
| 23 | Genuity Science | Series C | $200.0M | 2018-11-27 | Boston | Artificial intelligence |
| 24 | CARsgen Therapeutics | Series C | $186.0M | 2020-11-02 | Shanghai | Health care |
| 25 | Electra Therapeutics | Series C | $183.0M | 2025-10-22 | San Francisco | Biotech |
| 26 | Bluejay Therapeutics | Series C | $182.0M | 2024-05-09 | San Mateo | Biotech |
| 27 | Sionna Therapeutics | Series C | $182.0M | 2024-03-06 | Natick | Biotech |
| 28 | Deep Genomics | Series C | $180.0M | 2021-07-28 | Toronto | Artificial intelligence |
| 29 | Alpha-9 Oncology | Series C | $175.0M | 2024-10-23 | Vancouver | Biotech |
| 30 | Nutcracker Therapeutics | Series C | $167.0M | 2022-03-14 | Emeryville | Biotech |
| 31 | Mabworks | Series C | $160.0M | 2020-04-16 | Beijing | Biotech |
| 32 | Hemab | Series C | $157.0M | 2025-10-27 | Copenhagen | Biotech |
| 33 | RecBio | Series C | $156.3M | 2021-06-14 | Taizhou | Biotech |
| 34 | Brii Biosciences | Series C | $155.0M | 2021-03-23 | Beijing | Biotech |
| 35 | Hangzhou DAC Biotech Co., Ltd | Series C | $154.9M | 2021-05-12 | Hangzhou | Biotech |
| 36 | GKHT Medical Technology | Series C | $154.5M | 2019-09-09 | Beijing | Health care |
| 37 | Atsena Therapeutics | Series C | $150.0M | 2025-04-02 | Durham | Biotech |
| 38 | Scorpion Therapeutics | Series C | $150.0M | 2024-07-16 | Boston | Biotech |
| 39 | ConcertAI | Series C | $150.0M | 2022-03-29 | Cambridge | Artificial intelligence |
| 40 | Wheel | Series C | $150.0M | 2022-01-19 | Austin | Health care |
| 41 | SonderMind | Series C | $150.0M | 2021-07-28 | Denver | Fintech |
| 42 | MicroPort CRM | Series C | $150.0M | 2021-07-26 | Clamart | Health care |
| 43 | Hinova Pharma | Series C | $147.3M | 2020-10-06 | Chengdu | Health care |
| 44 | Element Science | Series C | $145.6M | 2020-03-03 | San Francisco | Biotech |
| 45 | CareBridge | Series C | $140.0M | 2022-06-08 | Nashville | Health care |
| 46 | Amolyt Pharma | Series C | $138.6M | 2023-01-06 | Écully | Biotech |
| 47 | Vividion Therapeutics | Series C | $135.0M | 2021-02-24 | San Diego | Biotech |
| 48 | Beyond Limits | Series C | $133.0M | 2020-09-22 | Glendale | Artificial intelligence |
| 49 | Endeavor BioMedicines | Series C | $132.5M | 2024-04-24 | Solana Beach | Biotech |
| 50 | Cloudbreak Therapeutics | Series C | $130.0M | 2022-01-01 | Irvine | Biotech |
| 51 | Luma Health | Series C | $130.0M | 2021-11-23 | San Mateo | Health care |
| 52 | Hippocratic AI | Series C | $126.0M | 2025-11-03 | Palo Alto | Artificial intelligence |
| 53 | Bohai New Enzyme | Series C | $125.0M | 2021-11-05 | Shanghai | Biotech |
| 54 | NexHealth | Series C | $125.0M | 2022-04-21 | San Francisco | Health care |
| 55 | Betterfly | Series C | $125.0M | 2022-02-01 | Santiago | Fintech |
| 56 | Hummingbird Bioscience | Series C | $125.0M | 2021-05-18 | Woodlands | Biotech |
| 57 | Tend | Series C | $125.0M | 2021-04-12 | Nashville | Health care |
| 58 | OneSource | Series C | $125.0M | 2021-03-19 | Bangalore | Biotech |
| 59 | Paige | Series C | $125.0M | 2021-01-14 | New York | Artificial intelligence |
| 60 | Senda Biosciences | Series C | $123.0M | 2022-08-16 | Cambridge | Biotech |
| 61 | Recens Medical | Series C | $122.0M | 2021-12-31 | Ulsan | Health care |
| 62 | Cellarity | Series C | $121.0M | 2022-10-04 | Somerville | Biotech |
| 63 | AusperBio | Series C | $120.0M | 2026-08-27 | San Mateo | Biotech |
| 64 | Assort Health | Series C | $120.0M | 2026-06-24 | San Francisco | Artificial intelligence |
| 65 | AKASA | Series C | $120.0M | 2024-06-18 | San Francisco | Artificial intelligence |
| 66 | Escient Pharmaceuticals | Series C | $120.0M | 2022-11-28 | San Diego | Biotech |
| 67 | Belief BioMed | Series C | $120.0M | 2022-04-01 | Minhang | Biotech |
| 68 | EpimAb Biotherapeutics | Series C | $120.0M | 2021-03-22 | Shanghai | Biotech |
| 69 | Aspen Neuroscience | Series C | $115.0M | 2025-11-20 | San Diego | Biotech |
| 70 | Glycomine | Series C | $115.0M | 2025-04-16 | San Carlos | Biotech |
| 71 | Nusano | Series C | $115.0M | 2024-10-01 | Valencia | Biotech |
| 72 | IntelyCare | Series C | $115.0M | 2022-04-06 | Quincy | Health care |
| 73 | Elektrofi | Series C | $112.2M | 2024-08-22 | Boston | Biotech |
| 74 | Harrison.ai | Series C | $112.0M | 2025-02-11 | Barongarook | Artificial intelligence |
| 75 | Bridge to Life | Series C | $110.0M | 2026-08-12 | Northbrook | Biotech |
| 76 | Capstan Medical | Series C | $110.0M | 2024-12-11 | Santa Cruz | Hardware |
| 77 | MMI | Series C | $110.0M | 2024-02-21 | Pisa | Hardware |
| 78 | Eyetech Pharmaceuticals | Series C | $108.5M | 2001-08-08 | New York | Biotech |
| 79 | Jun Shengtai | Series C | $107.0M | 2023-01-05 | Shenzhen | Biotech |
| 80 | Jnana Therapeutics | Series C | $107.0M | 2022-11-15 | Boston | Biotech |
| 81 | Cleerly | Series C | $106.0M | 2024-12-03 | Denver | Artificial intelligence |
| 82 | Annoroad | Series C | $105.5M | 2017-11-03 | Beijing | Biotech |
| 83 | Cognito Therapeutics | Series C | $105.0M | 2026-03-05 | Cambridge | Biotech |
| 84 | Geneoscopy | Series C | $105.0M | 2025-01-08 | Saint Louis | Biotech |
| 85 | Elpiscience Biopharmaceuticals | Series C | $105.0M | 2021-05-13 | Shanghai | Biotech |
| 86 | Arch Oncology | Series C | $105.0M | 2021-04-27 | St Louis | Biotech |
| 87 | Personal Genome Diagnostics | Series C | $103.0M | 2021-02-10 | Baltimore | Biotech |
| 88 | Tennr | Series C | $101.0M | 2025-06-18 | New York | Artificial intelligence |
| 89 | Cadence Solutions | Series C | $100.0M | 2026-06-23 | New York | Health care |
| 90 | Loyal | Series C | $100.0M | 2026-02-11 | San Francisco | Biotech |
| 91 | Galvanize Therapeutics | Series C | $100.0M | 2025-09-03 | Redwood City | Health care |
| 92 | Biolinq | Series C | $100.0M | 2025-03-19 | San Diego | Biotech |
| 93 | Umoja Biopharma | Series C | $100.0M | 2025-01-14 | Seattle | Biotech |
| 94 | SiteOne Therapeutics | Series C | $100.0M | 2024-12-18 | South San Francisco | Biotech |
| 95 | Autobahn Therapeutics | Series C | $100.0M | 2024-07-24 | San Diego | Biotech |
| 96 | Asceneuron | Series C | $100.0M | 2024-07-16 | Lausanne | Biotech |
| 97 | Karius | Series C | $100.0M | 2024-05-02 | Redwood City | Artificial intelligence |
| 98 | MitrAssist | Series C | $100.0M | 2023-09-26 | Misgav Dov | Biotech |
| 99 | Boundless Bio | Series C | $100.0M | 2023-05-16 | La Jolla | Biotech |
| 100 | Vytalize Health | Series C | $100.0M | 2023-02-22 | Hoboken | Health care |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,241.
By month
| Month | Companies |
|---|---|
| 2024-09 | 6 |
| 2024-10 | 9 |
| 2024-11 | 9 |
| 2024-12 | 16 |
| 2025-01 | 19 |
| 2025-02 | 9 |
| 2025-03 | 7 |
| 2025-04 | 10 |
| 2025-05 | 10 |
| 2025-06 | 10 |
| 2025-07 | 10 |
| 2025-08 | 12 |
| 2025-09 | 11 |
| 2025-10 | 17 |
| 2025-11 | 8 |
| 2025-12 | 11 |
| 2026-01 | 10 |
| 2026-02 | 11 |
| 2026-03 | 19 |
| 2026-04 | 13 |
| 2026-05 | 15 |
| 2026-06 | 11 |
| 2026-07 | 14 |
| 2026-08 | 7 |
Table 3. Health care startups that raised Series C by month of the round. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,241.
Country
| Country | Companies |
|---|---|
| United States | 613 |
| China | 307 |
| South Korea | 50 |
| United Kingdom | 43 |
| Japan | 32 |
| Israel | 28 |
| Germany | 22 |
| India | 21 |
| Switzerland | 20 |
| France | 19 |
| Canada | 14 |
| Singapore | 9 |
| Australia | 8 |
| The Netherlands | 7 |
| Sweden | 5 |
Table 4. Health care startups that raised Series C by country. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,241.
City
| City | Companies |
|---|---|
| San Francisco | 55 |
| Shanghai | 49 |
| Beijing | 41 |
| New York | 39 |
| Hangzhou | 33 |
| San Diego | 31 |
| Boston | 28 |
| Cambridge | 24 |
| Shenzhen | 24 |
| Suzhou | 22 |
| Seoul | 20 |
| Nanjing | 19 |
| Tokyo | 17 |
| Menlo Park | 17 |
| Guangzhou | 17 |
Table 5. Health care startups that raised Series C by city. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,241.
Sector
| Sector | Companies |
|---|---|
| Health care | 1,241 |
| Biotech | 620 |
| Software | 225 |
| Artificial intelligence | 90 |
| Hardware | 55 |
| Commerce | 39 |
| Fintech | 37 |
| Education | 13 |
| Energy | 6 |
| Cybersecurity | 4 |
Table 6. Health care startups that raised Series C by sector. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,241.
Health care at other stages
Other sectors that raised Series C
software startups that raised Series C2,384
AI startups that raised Series C589
fintech startups that raised Series C623
commerce startups that raised Series C639
hardware startups that raised Series C1,102
biotech startups that raised Series C700
education startups that raised Series C184
cybersecurity startups that raised Series C295
energy startups that raised Series C194
Cite: FundingWatcher, 1,241 health care companies whose most recent round is Series C, 4 September 2026. https://fundingwatcher.com/startups/health-care/series-c/